Montelukast for the treatment of asthma in the adult population

Author： Amlani Salima   Nadarajah Thanu   McIvor Richard Andrew  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.13, 2011-09, pp. : 2119-2128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A review of montelukast in the treatment of asthma and allergic rhinitis

By Nayak Anjuli  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 679-686

Informa Healthcare

Access to resources Recommend Favorite

Montelukast in children with asthma - new evidence

By  

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Montelukast an advantage for asthma and allergic rhinitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Comparison of Salmeterol/Fluticasone Propionate versus Montelukast in the Treatment of Adults with Persistent Asthma

By Sheth K.  

PharmacoEconomics, Vol. 20, Iss. 13, 2002-01 ,pp. : 909-918

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Fluticasone Propionate Plus Salmeterol Versus Fluticasone Propionate Plus Montelukast in the Treatment of Persistent Asthma

By Richard D. O’Connor  

PharmacoEconomics, Vol. 22, Iss. 12, 2004-01 ,pp. : 815-825

Adis International

Access to resources Recommend Favorite